Literature DB >> 25227413

Crucial components of Mycobacterium type II fatty acid biosynthesis (Fas-II) and their inhibitors.

Xiangke Duan1, Xiaohong Xiang, Jianping Xie.   

Abstract

Abundant mycolic acids are the hallmark of the mycobacterial cell wall. The biosynthesis of mycolic acids fulfilled by type I (Fas-I) and type II (Fas-II) synthase systems necessitates long chain fatty acids as the raw material. Fas-I is responsible for de novo fatty acid synthesis to form fatty acids 16-24 carbons in length and then elongated by the monofunctional enzymes of Fas-II to form long chain fatty acids, and further to form mycolic acids. Mutation of monofunctional enzymes can confer mycobacterial drug resistance. The key monofunctional enzymes of this system might represent new drug target candidates for antituberculosis drug development.
© 2014 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  inhibitor; mycobacteria; mycolic acid; screen model; type II fatty acid synthase

Mesh:

Substances:

Year:  2014        PMID: 25227413     DOI: 10.1111/1574-6968.12597

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  5 in total

1.  Structural insights into the EthR-DNA interaction using native mass spectrometry.

Authors:  Daniel Shiu-Hin Chan; Wei-Guang Seetoh; Brendan N McConnell; Dijana Matak-Vinković; Sherine E Thomas; Vitor Mendes; Michal Blaszczyk; Anthony G Coyne; Tom L Blundell; Chris Abell
Journal:  Chem Commun (Camb)       Date:  2017-03-23       Impact factor: 6.222

2.  Lack of Specificity of Phenotypic Screens for Inhibitors of the Mycobacterium tuberculosis FAS-II System.

Authors:  Anna E Grzegorzewicz; Joël Lelièvre; Jorge Esquivias; Bhanupriya Angala; Jiuyu Liu; Richard E Lee; Michael R McNeil; Mary Jackson
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

3.  Modeling Host-Pathogen Interaction to Elucidate the Metabolic Drug Response of Intracellular Mycobacterium tuberculosis.

Authors:  Rienk A Rienksma; Peter J Schaap; Vitor A P Martins Dos Santos; Maria Suarez-Diez
Journal:  Front Cell Infect Microbiol       Date:  2019-05-08       Impact factor: 5.293

Review 4.  Efficacy and Mechanisms of Flavonoids against the Emerging Opportunistic Nontuberculous Mycobacteria.

Authors:  Suresh Mickymaray; Faiz Abdulaziz Alfaiz; Anand Paramasivam
Journal:  Antibiotics (Basel)       Date:  2020-07-27

5.  Identification and validation of the mode of action of the chalcone anti-mycobacterial compounds.

Authors:  B Anagani; J Singh; J P Bassin; G S Besra; C Benham; T R K Reddy; J A G Cox; M Goyal
Journal:  Cell Surf       Date:  2020-05-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.